The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain
The rest is here:
FDA approves Cymbalta for treatment of chronic musculoskeletal pain – News-Medical.Net
